FR2580642B1 - 5-pyrimidinecarboxamides et traitement de la leucemie et des tumeurs en les utilisant - Google Patents

5-pyrimidinecarboxamides et traitement de la leucemie et des tumeurs en les utilisant

Info

Publication number
FR2580642B1
FR2580642B1 FR8605715A FR8605715A FR2580642B1 FR 2580642 B1 FR2580642 B1 FR 2580642B1 FR 8605715 A FR8605715 A FR 8605715A FR 8605715 A FR8605715 A FR 8605715A FR 2580642 B1 FR2580642 B1 FR 2580642B1
Authority
FR
France
Prior art keywords
pyrimidinecarboxamides
leukemia
tumors
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8605715A
Other languages
English (en)
Other versions
FR2580642A1 (fr
Inventor
Arthur D Brewer
John A Minatelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Uniroyal Chemical Co Inc
Original Assignee
Uniroyal Chemical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniroyal Chemical Co Inc filed Critical Uniroyal Chemical Co Inc
Publication of FR2580642A1 publication Critical patent/FR2580642A1/fr
Application granted granted Critical
Publication of FR2580642B1 publication Critical patent/FR2580642B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR8605715A 1985-04-22 1986-04-21 5-pyrimidinecarboxamides et traitement de la leucemie et des tumeurs en les utilisant Expired FR2580642B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/725,736 US4636508A (en) 1985-04-22 1985-04-22 5-pyrimidinecarboxyamides and treatment of leukemia therewith

Publications (2)

Publication Number Publication Date
FR2580642A1 FR2580642A1 (fr) 1986-10-24
FR2580642B1 true FR2580642B1 (fr) 1988-12-30

Family

ID=24915762

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8605715A Expired FR2580642B1 (fr) 1985-04-22 1986-04-21 5-pyrimidinecarboxamides et traitement de la leucemie et des tumeurs en les utilisant

Country Status (21)

Country Link
US (1) US4636508A (fr)
JP (1) JPS6259264A (fr)
CN (2) CN1014990B (fr)
AT (1) AT391864B (fr)
AU (3) AU592559B2 (fr)
BE (1) BE904641A (fr)
CA (1) CA1274509A (fr)
CH (1) CH668970A5 (fr)
DE (1) DE3613447A1 (fr)
DK (1) DK182986A (fr)
ES (3) ES8800671A1 (fr)
FR (1) FR2580642B1 (fr)
GB (1) GB2174391B (fr)
GR (1) GR861024B (fr)
IL (2) IL78576A0 (fr)
IT (1) IT1214499B (fr)
LU (1) LU86403A1 (fr)
NL (1) NL8601023A (fr)
NZ (1) NZ215874A (fr)
SE (1) SE8601826L (fr)
ZA (1) ZA862630B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845217A (en) * 1985-05-17 1989-07-04 Uniroyal Chemical Ltd./Ltee Purification of 5-pyrimidinecarboxamides
US4920126A (en) * 1988-05-10 1990-04-24 Uniroyal Chemical Ltd/Uniroyal Chemical Ltee Barbituric acid derivative and treatment of leukemia and tumors therewith
FR2628741A1 (fr) * 1988-07-14 1989-09-22 Uniroyal Chemical Ltd Nouveaux composes n-phenyl-5-pyrimidinecarboxamides et composition pharmaceutique les contenant utilisable pour induire la regression de la leucemie ou des tumeurs
FR2628869A1 (fr) * 1988-07-14 1989-09-22 Uniroyal Chemical Ltd
EP0430885A3 (en) * 1989-12-01 1991-11-06 Ciba-Geigy Ag Anthelmintical compounds
WO2003035076A1 (fr) * 2001-10-26 2003-05-01 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa Inhibiteurs de l'integrase du vih a base de dihydroxypyrimidine carboxamide
US9428466B2 (en) * 2013-11-13 2016-08-30 Raymond P. Warrell, Jr. Methods for reducing uric acid levels using barbiturate derivatives
US10093631B2 (en) * 2014-02-14 2018-10-09 Acquist Llc Bifunctional compounds and use for reducing uric acid levels
EP3247704A4 (fr) 2015-01-22 2018-10-03 Acquist LLC Composés bifonctionnels et leur utilisation pour la réduction des niveaux de l'acide urique
TWI772309B (zh) 2016-06-30 2022-08-01 美商艾克奎斯特有限責任公司 化合物及其於降低尿酸位準之用途(二)
WO2018009615A1 (fr) 2016-07-06 2018-01-11 Acquist Llc Composés et utilisation de ces derniers pour réduire les niveaux d'acide urique
WO2018200571A1 (fr) 2017-04-25 2018-11-01 Arbutus Biopharma Corporation Analogues de 2,3-dihydro-1h-indène substitués et leurs méthodes d'utilisation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670756A1 (de) * 1966-10-05 1970-12-23 Hoechst Ag Verfahren zur Herstellung von 6-Amino-uracil-5-carbonamid-N-sulfonamiden
DE2405733C2 (de) * 1974-02-07 1984-12-13 Bayer Ag, 5090 Leverkusen Amidocarbonylthiobarbitursäurederivate und deren Salze, Verfahren zu ihrer Herstellung sowie ihre Verwendung zur Bekämpfung von Insekten, Milben und Pilzen
CH614944A5 (en) * 1974-04-16 1979-12-28 Sandoz Ag Process for the preparation of novel pyrimidine derivatives
DE2719777A1 (de) * 1976-05-06 1977-11-24 Ciba Geigy Ag Neue 5-phenylcarbamoyl-barbitursaeuren
PL103086B1 (pl) * 1976-05-06 1979-05-31 Ciba Geigy Ag Srodek owadobojczy
US4283444A (en) * 1978-09-12 1981-08-11 Ciba-Geigy Corporation Method of protecting keratinous material from attack by insects that feed on keratin by treatment with 5-phenylcarbamoylbarbituric acid compounds
US4349552A (en) * 1978-10-30 1982-09-14 Fujisawa Pharmaceutical Company, Ltd. 5-Fluorouracil derivatives, and their pharmaceutical compositions
JPS5625166A (en) * 1979-08-09 1981-03-10 Banyu Pharmaceut Co Ltd 5-fluorouracil derivative
JPS5843960A (ja) * 1981-09-10 1983-03-14 Shoichiro Ozaki ５−フルオロウラシル誘導体，その製造法および制ガン剤
DE3347795A1 (de) * 1983-01-14 1985-08-01 Ozaki, Shoichiro, Ehime Neue 1-(n-substituierte carbamoyl)-5-fluorouracil-derivate und krebshemmende mittel, in denen sie als aktive bestandteile enthalten sind
JPS6012322A (ja) * 1983-07-01 1985-01-22 Toyota Motor Corp 四リンク型サスペンシヨン
IL73840A (en) * 1983-12-19 1988-11-15 Uniroyal Chem Co Inc 2-thio-5-(thio)carbamoyl barbituric acid derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AU592559B2 (en) 1990-01-18
ATA101986A (de) 1990-06-15
DK182986A (da) 1986-10-23
CH668970A5 (de) 1989-02-15
AU5641886A (en) 1986-10-30
GR861024B (en) 1986-08-14
IT8620153A0 (it) 1986-04-18
CN1014990B (zh) 1991-12-04
DK182986D0 (da) 1986-04-21
NL8601023A (nl) 1986-11-17
GB2174391B (en) 1988-12-29
CN1038450A (zh) 1990-01-03
BE904641A (fr) 1986-10-21
DE3613447A1 (de) 1986-10-30
IT1214499B (it) 1990-01-18
JPS6259264A (ja) 1987-03-14
IL86711A0 (en) 1988-11-30
ES8801219A1 (es) 1987-12-16
SE8601826D0 (sv) 1986-04-21
GB2174391A (en) 1986-11-05
US4636508A (en) 1987-01-13
ES8801220A1 (es) 1988-01-01
FR2580642A1 (fr) 1986-10-24
DE3613447C2 (fr) 1991-04-11
ES557684A0 (es) 1988-01-01
NZ215874A (en) 1988-09-29
ES557683A0 (es) 1987-12-16
AU2219588A (en) 1989-01-05
ES8800671A1 (es) 1987-11-16
LU86403A1 (fr) 1987-12-07
ES554245A0 (es) 1987-11-16
AT391864B (de) 1990-12-10
GB8609244D0 (en) 1986-05-21
SE8601826L (sv) 1986-10-23
CN86102767A (zh) 1987-01-07
CA1274509A (fr) 1990-09-25
ZA862630B (en) 1986-11-26
AU2219688A (en) 1989-01-05
IL78576A0 (en) 1986-08-31

Similar Documents

Publication Publication Date Title
ZA864025B (en) Treatment of tobacco
DE3568137D1 (en) Treatment of allergy
MX164573B (es) Tratamiento de efluentes de cianuro-ferrocianuro
FR2580642B1 (fr) 5-pyrimidinecarboxamides et traitement de la leucemie et des tumeurs en les utilisant
DK232386A (da) Fraebehandling
DK245686A (da) Hidtil ukendt behandling
IT1203738B (it) Bilirubin-cssidasi termostabile e procedimento per produrla
BR8807280A (pt) Tratamento de membranas permeaveis
DK31386A (da) Behandling af proliferative hudsygdomme
DK293086D0 (da) Hidtil ukendt behandling
GB8517436D0 (en) Treatment of horses
DK135486A (da) Efterbehandlet protetisk organ
GB8525633D0 (en) Treatment of gases
GB2181666B (en) Treatment of gases
KR870700350A (ko) 간염의 치료방법
GB8627395D0 (en) Treatment of scares
GB8603461D0 (en) Treatment of stitchware
BR8504188A (pt) Preparacao de terpinen-4-ois
GB8501374D0 (en) Treatment of aids
RO92640A2 (fr) Methode pour le traitement des keratites virotiques
RO92461A2 (fr) Solution medicamenteuse pour la prevention et la therapie des affections parodontales
SE8802931D0 (sv) 5-pyrimidinecarboxamides and treatment of leukemia and tumors therewith
RO93154A2 (fr) Simili-cuir et procede d'obtention
FR2584071B2 (fr) Acides dihydro-5,6-4h-cyclopenta (b) thiophenecarboxyliques-6, procedes de preparation et medicaments les contenant
PH25584A (en) Method of treating human viralk infections

Legal Events

Date Code Title Description
ST Notification of lapse